H
Herophilus utilizes next-generation scaled complex in vitro models to accelerate the discovery of neurotherapeutics for neurological disorders. The company addresses the limitations of traditional drug development methods by providing more accurate biological insights and reducing the time and cost associated with bringing new treatments to market.
Updated 20 months ago
Funding
$16M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
KV
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Herophilus utilizes next-generation scaled complex in vitro models to accelerate the discovery of neurotherapeutics for neurological disorders. The company addresses the limitations of traditional drug development methods by providing more accurate biological insights and reducing the time and cost associated with bringing new treatments to market.